The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
Anyway, another good day for the company not reflected in the SP just yet.
The time will come...
The positive building blocks continue to be placed into position.
Good to see, Accustem is progressing fine and all is well.
Please can people stop dripping about having no Accustem shares showing in their accounts. It is down to the broker, not the company.
As long as you were a holder on the record date you have nothing to worry about and are covered legally.
I have no shares showing in my Barclays account but shares showing in my HL account.
Lolmcshizz, even if it’s just an interview to explain things are progressing as planned but there’s been a few unforeseen delays it will be a positive.
Some investors have been getting edgy and even if GC just reassures people it will go a long way and keep things bubbling along in the background nicely.
It’s been a patient wait but things are starting to get interesting again now, roll on tomorrow evening.
Could tomorrow be the catalyst for the next leg up?
Some were hoping the SP would go lower and will miss the boat completely...
Others will sell along the way up expecting the usual TILS retreat..
Me? I’m going to hang on for the ride as I believe TILS will find an upward straight line at some point and not bother coming back! It’s just a case of when?
Good luck to all whatever your strategy.
Positive talk about TILS. I have to agree, TILS will be the one that got away for some. Not me..
If the Brazil trial was that successful you would hope the doctors of the hospital which carried out the trial are pushing to use Foralumab ASAP.
I’m sure word will travel fast amongst the medical community of São Paulo and you’d also hope private hospitals there will be asking the relevant questions surrounding accessibility to the drug.
Mothers milk, you know you can do a members search if you miss JAdam? He is still in the thick of things elsewhere.
The company has moved on very well since those days and has had an excellent year in terms of progression.
Still very much under the radar which offers a buying opportunity to those that believe.
Just a case of when now. No concerns here.
Some fella once said “the stock market is a device for transferring money from the impatient to the patient".
This will prove very correct with TILS.
Agreed Dreamchaser, this looks like base camp. The SP has been around this area for 3 weeks now and looking strong. The wise have used it as an opportunity to top up and average down.
You just get the sense that it’s about to move upwards.
Looking strong over the pond this evening, UK equivalent would be £1.15.
News is due..
Any trial that is paid for by the US government sounds like a no brainer to investors but maybe it just isn’t part of the strategy.
Big pharma are pulling the strings in the background and telling the BOD what they need to do, we already know that. GC is savvy, been around a while and is out to achieve maximum financial reward for his efforts. He obviously feels that the value lies in a takeover or sellout from a big pharma rather than being railroaded into a different direction by the US government.
Physical, it’s a bit of a head scratcher as to where the Covid-19 progress is on the website under the drug pipeline section?
I did email the company a couple of evenings ago but still awaiting a reply.
Maybe it’s because all the other patents have been approved but the patent for the nasal administration of Foralumab for Covid 19 patients is still under the application phase? It was applied for in late July so we can expect to hear something within Q1 or Q2.
For the record, I am not concerned. Tiziana has so many other options to fall back on and that is the reason I chose to invest in TILS over other similar companies.
Wow, huge rise for an already multi billion dollar company. Up 34% and rising.
The mind boggles as to what could happen with the TILS share price once things really get going.
Let’s hope things are accelerating in the background because this is an unbelievable opportunity for the company.
Interesting article. It states:
‘No antibody therapies have so far been approved in the UK, where the only hospital treatments for Covid patients are steroids for people already on ventilators or with dangerously low oxygen levels’.
Please correct me if I’m wrong but I was under the impression Tocilizumab was being used alongside Dexamethasone as a treatment in the UK?
The website has been like this for a couple of weeks.
I have emailed the company this evening and asked them to update the drug pipeline to include the nasal administration of Foralumab for COVID-19.
The BOD stated in October that the StemprintER validation would take 4-6 months so on target as far as I’m concerned.
I imagine there is a hive of activity going on in the background for both companies at the moment.
I am expecting additional analyst valuations for both Tiziana and Accustem within the next month or two.
Denny, you’re probably not alone in seeing people post their buys on here but then some people, like myself and others find it interesting as an indication of price action. The listed buys/sells are not clear cut in this country and it is good to see what other genuine posters are doing at times buying wise.
I am not here to ‘Willy wave’ as you call it and quite often provide information to help other posters if they ask a question.
Cheers Trade&MRK, yes that was the header I posted under. So LSE don’t like a post header and they then withdraw all the other posts under that header?
I’m still trying to work out what was wrong with this header??
Seems blimin’ shady to me, I don’t like it.
Hmmmm, not convinced it’s just quiet. Some dark forces at work IMO.
I made two chunky buys at 12.08 today of 10k and 6k, posted them at 12.09 and the post then mysteriously disappeared.
I have had the same thing happen to me on LSE before and the SP moved north pretty rapidly on that occasion.
Is anyone else posting here today, all seems very strange? LSE seems to be working fine on other stocks...Did Iceman get his top up?